Funding Roundup
M&A: Spectranetics prepares $200M offering to fund $230M AngioScore bid
Mass. General gets $30M DoD grant to build brain implant for mental illness | MassDevice.com On Call
MASSDEVICE ON CALL — Researchers at Massachusetts General Hospital were recipients of a $30 million grant to build brain implants for treating mental illness, targeting combat veterans coming home with brain injuries, depression and post-traumatic stress disorder.
Consano raises $3.9M to connect researchers with funders
Consano raised $3.9 million in 10 days in support of its mission to connect individual donors with vetted medical research projects.
HistoSonics pulls in $14M | Medtech funding for the week of May 19, 2014
mHealth: iRhythm raises $17M for Zio wearable monitor
Remote monitoring startup iRhythm touted a new $17 million Series E funding round in support of its wearable devices, saying it plans to pursue efforts in commercialization, marketing and clinical studies.
The San Francisco company offers continuous cardiac monitoring with its FDA-cleared Zio wearable device and accompanying software. The system is designed to log data on patients’ heart rhythms, then process and analyze the data to kick out a report for physicians.
Allied Minds prepares $140M U.K. IPO to support U.S. R&D
Boston-based innovation development group Allied Minds is planning a $140 million (£83 million) initial public offering on the London Stock Exchange in support of its effort to commercialize products in the U.S.
HistoSonics nears close of $14.2M funding for non-invasive ablation
Michigan medical device maker HistoSonics is creeping toward the close of a $14.22 million funding round in support of its non-invasive tissue ablation technology.
The company has raised about $14.17 million so far from 13 unnamed investors, through sales of equity, options, warrants and other rights to acquire securities, according to an SEC filing dated May 16.
Israel-based Keystone Heart raises $14M for cerebral protection
Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.
Ceterix Orthopaedics raises $18M for surgical tools
California-based Ceterix Orthopaedics plans to boost its marketing efforts with the help of $18 million in new financing.
The company hopes to widen the reach of its surgical tools, which help physicians place stitches in hard-to-reach places while protecting other tissue. Ceterix’s technology is currently in use by more than 100 physicians in the U.S., according to a company statement.